NCT05656976Active, not recruiting
Efficacy of Offering a Self-sampling Device by the GP to Reach Underscreened Women
Efficacy of Offering a Self-sampling Device by the General Practitioner to Reach Women Underscreened in the Routine Cervical Cancer Screening Program Compared to Sending Reminder Letters by the Screening Organization
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
The ESSAG trial invests the impact of offering a free self-sampling device (SSD) on the cervical cancer screening rate of underscreened women. This study is aimed at women between the age of 31 and 64 who did not have a smear taken during the last 6 years. In order to assess the effect of a) providing the SSD, and b) the intervention of the general practitioner (GP) (either face-to-face, either by sending the SSD by letter), a cluster randomized control trial is set up with three arms. The ESSAG trial evolves from a collaboration between Universiteit Gent and Vrije Universiteit Brussel, Katholieke Universiteit Leuven, Universiteit Antwerpen, Sciensano, het Centrum voor Kankeropsporing en het Belgisch Kankerregister, and is funded by "Kom Op Tegen Kanker".
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 3375 (estimated)
- First submitted
- 23 Nov 2022
- Start date
- 1 Sept 2023
- Primary completion date
- 31 Aug 2024
- Lead sponsor
- University Ghent
- Diseases
- Cervical cancer
- NCT number
- NCT05656976
What you commit to
- Study type: Interventional
- Planned participants: 3375
- From 1 Sept 2023 to the primary completion date, 31 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- (past) diagnosis of cervical cancer
Other
- hysterectomy
- pregnancy
Who the study is looking for
- women between 31-64 years old
- living in Flanders
- eligible for the Flemish actions with regard to population screening
- without a smear registered in the Belgian Cancer Registry in the last 6 years
- registered as GMD patient in one of the participating GP practices
Age in the registry: 31 years to 64 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ghent University Coordinator of this site? Confirm its status | Ghent | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.